Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis
Clara M. Castillejo Becerra(Mayo Clinic in Arizona), John J. Chen(Mayo Clinic in Arizona), Matthew J. Koster(Mayo Clinic in Arizona), Deena Tajfirouz(Anna Needs Neuroblastoma Answers), Hannah E. Langenfeld(Mayo Clinic in Arizona), Kevin D. Chodnicki(Mayo Clinic), Cynthia S. Crowson(Mayo Clinic)
Cited by 2
Related Papers
Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders
|JAMA Neurology|2018|408
Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome
|American Journal of Ophthalmology|2018|402
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
|Neurology|2020|231
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
|The American Journal of Medicine|1992|225
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
|JAMA Neurology|2021|218